Financials Nova Cannabis Inc.

Equities

NOVC

CA66980W1041

Drug Retailers

Delayed Toronto S.E. 11:07:03 2024-05-10 am EDT 5-day change 1st Jan Change
1.3 CAD +2.36% Intraday chart for Nova Cannabis Inc. -8.45% +46.07%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 160.4 70.87 50.91 72.81 -
Enterprise Value (EV) 1 160.4 70.87 50.91 72.81 72.81
P/E ratio -7.21 x - - - -
Yield - - - - -
Capitalization / Revenue - 0.31 x 0.2 x 0.26 x 0.22 x
EV / Revenue - 0.31 x 0.2 x 0.26 x 0.22 x
EV / EBITDA - 11.1 x 2.33 x 3.02 x 2.03 x
EV / FCF - -8.36 x - 7.21 x 4.77 x
FCF Yield - -12% - 13.9% 21%
Price to Book - - - - -
Nbr of stocks (in thousands) 57,093 57,155 57,206 57,331 -
Reference price 2 2.810 1.240 0.8900 1.270 1.270
Announcement Date 3/21/22 3/29/23 3/26/24 - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 63.31 - 226.4 259.3 279.2 323.6
EBITDA 1 - - 6.412 21.83 24.1 35.9
EBIT 1 - - -7.542 - 12.7 22
Operating Margin - - -3.33% - 4.55% 6.8%
Earnings before Tax (EBT) - - - - - -
Net income -2.073 -20.61 - - - -
Net margin -3.27% - - - - -
EPS - -0.3900 - - - -
Free Cash Flow 1 - - -8.473 - 10.1 15.27
FCF margin - - -3.74% - 3.62% 4.72%
FCF Conversion (EBITDA) - - - - 41.93% 42.53%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/13/21 3/21/22 3/29/23 3/26/24 - -
1CAD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 47.6 49.83 56.3 58.91 61.38 - 67.4 64.26 70.28 72.48 75.53
EBITDA 1 0.012 -0.174 2.104 2.279 2.203 - 6.391 4.481 5.6 6.6 7.4
EBIT - - - - - - - - - - -
Operating Margin - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - -
Net income - - -1.37 - - 2.097 - - - - -
Net margin - - -2.43% - - - - - - - -
EPS - - -0.0200 - - 0.0400 - - - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 3/21/22 5/9/22 8/12/22 11/8/22 3/29/23 11/8/23 3/26/24 5/8/24 - - -
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - -8.47 - 10.1 15.3
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - - 8.41 - 5.9 6.18
Capex / Sales - - 3.71% - 2.11% 1.91%
Announcement Date 4/13/21 3/21/22 3/29/23 3/26/24 - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.27 CAD
Average target price
3.75 CAD
Spread / Average Target
+195.28%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NOVC Stock
  4. Financials Nova Cannabis Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW